← Open Payments lookup

DANIEL CARDUCCI: Open Payments

NPI 1669812731 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,719 in 131 payments from 25 companies in 2025. Trend: 2023 $1,834 · 2024 $1,914 · 2025 $1,719

Food & beverage: $1,719
CompanyPaymentsAmount
Novo Nordisk Inc27$328
AstraZeneca Pharmaceuticals LP9$196
ABBVIE INC.15$183
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$180
Lilly USA, LLC23$149
Exact Sciences Corporation4$73
Otsuka America Pharmaceutical, Inc.4$69
GlaxoSmithKline, LLC.4$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Abbott Laboratories3$52

Products named: XIFAXAN, Wegovy, Ozempic, FARXIGA, REXULTI, MOUNJARO, QULIPTA, Cologuard Collection Kit.

Industry payments across NJ — which companies pay providers there.